The purpose of this study is to evaluate the web tool #HerHeart's usability and feasibility in adolescent and young adult women (AYA) and the opinion of their healthcare providers (HCP).
The objective of the proposed research is to increase young women's perceived susceptibility to CVD and provide a cue to action to adopt heart-healthy behaviors. The aim of the proposed study is to evaluate the usability and initial feasibility of #HerHeart. The investigators will recruit 30 AYA participants and will ask 10 HCPs to evaluate the usability and feasibility of the web tool. The study population will include female patients ages 13-21 years from the CHOA Adolescent Medicine Practice and Grady Teen Health Program. Part of our study population will be considered vulnerable (children under the age of 18 years). Subjects will be recruited via phone in advance of a clinical visit, from the waiting rooms of each clinic at the time of their appointment (in-person) or via Zoom at a time scheduled after their telehealth appointment (virtual). Written informed consent will be obtained for subjects 18 years and older. For subjects younger than 18 years, written parental permission (unless doing so would violate the adolescents' right to privacy, in which the Waiver of Parental Permission will be invoked) and written informed assent will be obtained. All consent procedures will take place in a private research room of each clinic (for in-person visits) or via Zoom videoconferencing (for virtual visits). Participants who agree to participate will attend a study visit at the Emory Children's Center Research Unit. Data for this study will be collected from participants via surveys/questionnaires, and semi-structured interviews that will be audio-recorded. Data collected will include demographic information, cardiovascular disease risk information, health metrics (BMI, blood pressure), cognitive data (perceived stress, quality of life), and participant feedback on a mobile app intervention. All subjects will receive a study identification number. Only the PI will have the codes linking the study identification numbers to subjects and these codes will be stored in a locked cabinet. All data will be collected in a private research room in the clinics (in-person visits) or in a password-protected Zoom videoconference (virtual). All study staff will complete biomedical or socio-behavioral training through the Collaborative IRB Training Initiative Program (CITI). Data will be stored on the Emory servers in password-protected files.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
PREVENTION
Masking
NONE
Enrollment
60
An integrated application consisting of a lifestyle-based CVD risk assessment and companion behavioral intervention. It will be administered at baseline and 3 months follow-up.
Children's Healthcare of Atlanta - Hughes Spalding Research Room
Atlanta, Georgia, United States
Grady Health System
Atlanta, Georgia, United States
#HerHEART Risk Score in AYA From Baseline
Risk is assessed based on answers surrounding the most critical diet and lifestyle factors that can influence a person's CVD risk. The factors include exercise, intake of fruits, vegetables, grains, nuts, sugary beverages and red/processed meats, and exercise. The Healthy Heart Score algorithm will be used to calculate the relative percent risk score of participants. Participants with a higher percent risk score have a higher risk for CVD based on their current reported habits. Those at low risk will have a risk score \<10%, moderate risk a risk score between 10 and 15%, and high risk a score above 15%.
Time frame: Baseline, 3 months post-enrollment
Overall Composite of Diet Score
Diet score = (0.03626 × grams/d of cereal fiber + 0.18283 \[if fruits + vegetables ≥3 servings/d\] + 0.14522 \[if nuts 0.1-1 servings/d + 0.2444 \[if nuts \>1 servings/d\]- 0.14631 × servings/d of sugar-sweetened beverages - 0.15624 × servings/d of red and processed meats)\*10 A higher score implies better diet quality. An increase in diet score correlates with a better outcome.
Time frame: Baseline, 3 months months post-enrollment
Fruit and Vegetable Intake
Intake will be measured with number of servings per day. Increase in servings/day correlates with a better outcome.
Time frame: Baseline, 3 months post- post-enrollment
Red and Processed Meats Intake
Intake will be measured with number of servings per day. A decrease in consumption is associated with a better outcome.
Time frame: Baseline, 3 months post-enrollment
Sugar and Sweetened Beverages
Intake will be measured with number of servings per week. A decrease in consumption is associated with a better outcome.
Time frame: Baseline, 3 months post-enrollment
Nut Consumption
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Intake will be measured with number of servings per week. An increase in intake is associated with a better outcome.
Time frame: Baseline, 3 months post-intervention
Alcohol Consumption
Number of participants who consume alcohol will be collected. No alcohol consumption is associated with a better outcome.
Time frame: Baseline, 3 months post-enrollment
Nicotine Use
Self-reported smoker status will be obtained and classified as: Never smoke, used to smoke, current smoker. Investigators will look at changes in smoking status where a decrease in use is associated with a better outcome.
Time frame: Baseline, 3 months post-enrollment
Cereal Fiber
Consumption of cereal will be measured in g/day. An increase in cereal fiber is associated with a better outcome.
Time frame: Baseline, 3 months post-enrollment
Physical Activity
Physical activity will be measured in number of hours per week. Increase in physical activity associated with a better outcome.
Time frame: Baseline, 3 months post-enrollment
BMI From Baseline
AYA participant's BMI will be measured during the clinic appointment when participant is recruited. AYA participants will then be asked to return for a study visit 3 months post intervention where their BMI will be measured again. Change in BMI will be measured with a decrease in BMI being associated with a positive outcome and an increase in BMI being associated with a negative outcome.
Time frame: Baseline, 3 month post-enrollment
Systolic Blood Pressure (BP) From Baseline
AYA participants' systolic BP (SBP) will be measured during the clinic appointment when the participant is recruited. AYA participants will then be asked to return for a study visit 3 months post-intervention where their BP will be measured again. Change in SBP will be measured with a decrease in SBP being associated with a positive outcome and an increase in SBP being associated with a negative outcome.
Time frame: Baseline, 3 month post-enrollment
Diastolic Blood Pressure (BP) From Baseline
AYA participants' diastolic BP (DBP) will be measured during the clinic appointment when the participant is recruited. AYA participants will then be asked to return for a study visit 3 months post-intervention where their BP will be measured again. Change in DBP will be measured with a decrease in diastolic BP being associated with a positive outcome and an increase in BP being associated with a negative outcome.
Time frame: Baseline, 3 month post-enrollment